Numerous authors have reported on the relationships between lichen and hepatic diseases, such as primary biliary cirrhosis, alcoholic cirrhosis or virus B hepatitis [1], To our knowledge, however, since the advent of the everyday practice of virus C serology, no work has been devoted to this possible association, other than one recent observation [2]. We have recently seen 2 cases with such an association; the treatment of the hepatitis with interferon alfa coincided with the total and prolonged disappearance of the lichen planus, which was generalized in one case and buccal in the other. Report of Two Cases A 40-year-old man presented a generalized and highly pruritic lichen planus that appeared within a few days in December 1989. The diagnosis was confirmed by biopsy. Liver function tests showed: aspartate amino-transferase 108 U/l (normal 7^10), alanine aminotransferase 44 U/l (normal 5-50) and γ-glutamyltransferase 182 U/l (normal < 30). Anti-hepatitis antibodies (Elisa Abbot and RIBA 2-Chiron) were evidenced. Serologic tests for anti-HlV-1 and -2 antibodies were negative. A liver biopsy revealed chronic hepatitis (Knodell score of 8). In 1984 the patient had suffered a severe traffic accident with multiple fractures requiring blood transfusions. A series of 4 sessions of PUVA therapy was performed associated with local cortico-steroids. with only a very slight improvement of the lesions. A treatment with interferon alfa (Rofe-ron®) was then undertaken, at a dose of 3 million units, 3 times a week, for 6 months. Tolerance was good, but the hepatopathy improved only slightly. However, the lichen planus lesions disappeared completely even though the patient had not followed any local treatment. Nine months after the end of the interferon treatment, there was no sign of recurrence. A 42-year-old man had hepatic cytolysis in 1981, with an absence of the virus A and B markers. A buccal lichen involving the tongue and inner aspects of the cheeks appeared in March 1989, little influenced by local treatment. In 1991, the cytolysis was still present (aspartate aminotransferase Ill U/l, alanine aminotransferase 57 U/l, γ-glutamyl-transferase20 U/l). Antihepatitis-C antibodies were then evidenced (Elisa-RIBA 1). A liver biopsy revealed an active
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